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Background/aim: The aims of this study were to determine the levels of the total antioxidant status (TAS), the total oxidant status
(TOS), the oxidative stress index (OSI), and the concentration of immunoglobulin A (IgA) and M (IgM) in colostrum, and evaluate
relationships between these parameters and maternal age, maternal parity, and infant sex.
Materials and methods: The analysis was performed in serum samples of colostrum which were collected from 90 mothers on the first
day of lactation between 10:00 and 12:00 AM.
Results: The measurements established that no significant association existed between the TAS level of colostrum and parity, maternal
age, or infant sex. However, mothers 18 to 30 years of age had significantly lower colostrum TOS and OSI levels compared with
mothers older than 30 years of age. IgA and IgM values of the colostrum of primiparous mothers were significantly higher than those of
multiparous mothers, whereas no correlations existed with the age of the mother. Additionally, significantly higher colostrum IgA and
IgM values were observed in female infants fed colostrum compared with male infants.
Conclusion: In conclusion, sex-based hormonal changes in mothers during pregnancy may be associated with the different colostral
immunoglobulin levels for male and female infants.
Key words: Total antioxidant status, total oxidant status, breast milk

1. Introduction
Because optimal growth and development of infants is
possible only with breast-feeding, breast milk is considered
to be the gold standard for infant nutrition. Breast milk
transmits nutrients to the infant, affects biochemical
systems, enhances immunity, and eliminates many
pathogens.
Increased concentrations of the oxidation products of
lipids, proteins, and nucleic acids in bodily fluids indicate
oxidative stress. The balance between the oxidation
power of reactive oxygen species (ROS) and antioxidant
defense mechanisms determines the degree of oxidative
stress. The aim of the antioxidant defense system is to
protect the organism against the adverse effects of ROSs
(1). Infants are exposed to increased oxidative stress
due to increased ROS production during delivery and a

decrease in antioxidative components, such as vitamin E
or glutathione peroxidase (2). Immunoglobulin A (IgA) is
the principal immunoglobulin in colostrum and milk. IgA
concentrations decline by the fourth week postpartum.
However, significant levels of IgA are maintained in milk
during the first year of lactation and in the second year
of life, milk contains considerable amounts of IgA even
if a baby is partially breast-fed (3). IgA levels may vary
according to the personal characteristics of the mother
and the gestational age of the baby. More IgA and immune
factors are found in the colostrum and the milk of mothers
who deliver preterm ( <37 weeks) compared to a longer
birth term (37–42 weeks) (4). The IgM concentration
in colostrum is low and decreases progressively during
lactation because IgM is produced by the neonate soon
after birth in response to infection (5). Compared to IgA
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concentrations, IgM concentrations exhibit less variability
associated with the personal characteristics of the mother
and the gestational age of the baby. No changes in IgM
concentrations were observed in the colostrum and milk
of mothers who gave birth at preterm compared to those
of mothers who gave birth at full term (5,6). Similar to
IgA, IgM levels were higher in primiparous mothers than
in multiparous mothers (7).
The purpose of the current study was to (1) investigate
the levels of the total antioxidant status (TAS), the total
oxidant status (TOS), the oxidative stress index (OSI), and
the concentration of IgA and IgM in the colostrum, and
(2) evaluate relationships between these parameters and
maternal age, maternal parity, and infant sex.
2. Materials and methods
2.1. Subjects
This study was performed according to the rules of the
ethics committee of Gaziantep University (Gaziantep,
Turkey) and with informed consent from the mothers.
Inclusion criteria for mothers were spontaneous vaginal
delivery (SVD) at term, absence of premature or postmature
birth, absence of any complications of pregnancy, delivery,
and puerperium (particularly hypertension, eclampsia,
infection, dystocia, or agalactia), and absence of plastic
surgery in mammary. Inclusion criteria for the neonates
comprised a birth weight of 2500–4000 g, absence of
fetal distress, birth asphyxia, sepsis, major congenital
abnormalities, or other significant diseases.
2.2. Sample collection and preparation
Colostrum samples were obtained from mothers on
the first day of lactation between 10:00 and 12:00 AM
from January to March 2013 using a commercial breast
pump. Samples were frozen immediately and stored at
−80 °C until analysis. Collection dates and times were
recorded as were the demographic and anthropometrical
characteristics of the infants and the mothers (Table 1).
The previous suckling occurred approximately 2 h prior to
sample collection.
Colostrum samples were prepared using a double
centrifugal process. Samples were allowed to reach ambient
temperature until dissolved. After thawing, colostrum
samples were centrifuged for 10 min at 680 × g at 4 °C, after
which the lipid layer and cellular elements were removed.
The aqueous fraction was centrifuged again for 30 min at
10,000 × g at 4 °C, and the lipid layer and cellular elements
were removed. Clear, ready-to-use serum fractions were
separated into 1.5 mL sterile tubes for measurements (8).
2.3. Measurement of colostrum TAS, TOS, and OSI levels
The TAS, TOS, and OSI levels of the serum were measured
using an automated analyzer (Tokyo Boeki, Prestige 24,
Tokyo, Japan) with a commercially available measurement
kit for TAS (Rel Assay Diagnostics, Gaziantep, Turkey)
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Table 1. Maternal and infant characteristics.
Characteristics

N (%)

Maternal age

Mean ± SD
(min–max)
28.11 ± 6.8

18–30

61 (67.8)

>30

29 (32.2)

Parity

3.13 ± 1.9

Primiparous

18 (20)

Multiparous

72 (80)

Sex
Female

39 (43.3)

Male

51 (56.7)

Birth weight (g)

90 (100)

3215.92 ± 387
(2500–4000)

Birth height (cm)

90 (100)

49.78 ± 0.7
(48–52)

Birth week

90 (100)

39.24 ± 0.9
(37–40)

Type of delivery

90 (100)

SVD

(9) and TOS (Rel Assay Diagnostics, Gaziantep, Turkey)
developed by Erel (10). The OSI index was expressed as
a percentage ratio of the TOS level to the TAS level. For
calculation, the units of the TAS concentration were
changed to mmol/L, and the OSI value was calculated
according to the following formula: OSI (arbitrary unit)
= TOS (μmol H2O2 equiv/L) / TAS (mmol Trolox equiv/L)
(11).
2.4. Determination of colostrum IgA and IgM concentrations
Serum IgA and IgM levels were detected by nephelometry
(BN ProSpec, Siemens Healthcare Diagnostics, Marburg,
Germany) using commercially available kits (Siemens N
Antiserum to Human IgA, Siemens N Antiserum to Human
IgM) according to the manufacturer’s instructions.
2.4.1. Statistical analysis
Statistical analyses were performed using the Statistical
Package for Social Science (SPSS) Version 22.0. Multiple
linear regression models were built for comparison of
adjusted means with the colostrum samples and also for
statistical comparisons between all group measurements.
Descriptive statistics for numerical variables were
expressed as the mean ± standard deviation (SD); P-values
less than 0.05 were considered significant.
3. Results
Maternal and infant characteristics are listed in Table 1.
The levels of TAS, TOS, and OSI values determined in
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Table 2. Levels of TAS, TOS, and OSI.
Groups

TAS (mmol
P
Trolox equiv/L)

Sex

Regression
coefficients

TOS (μmol
H2O2 Equiv/L)

B

Female

1.85 ± 0.2

Male

1.84 ± 0.2

0.90

Regression
OSI
coefficients

P

P

B

0.006

2.81 ± 1.6

Regression
coefficients

B

0.51

−0.21

2.79 ± 1.3

0.15 ± 0.08

0.46

−0.01

0.04*

0.03

0.73

−0.07

0.15 ± 0.06

Maternal age
18–30

1.84 ± 0.2

>30

1.86 ± 0.3

0.51

0.033

2.57 ± 1.3

0.04* 0.73

3.28 ± 1.4

0.14 ± 0.06
0.17 ± 0.07

Parity
Primiparous

1.90 ± 0.2

Multiparous

1.83 ± 0.2

General mean

1.84 ± 0.2

0.17

−0.08

2.76 ± 1.3

0.48

−0.28

2.81 ± 1.4

0.15 ± 0.07

2.80 ± 1.4

-

0.14 ± 0.05
0.15 ± 0.07

-

-

Data are presented as mean ± SD, and P-value from multiple linear regression analysis.
* P < 0.05.
Table 3. Concentrations of IgA and IgM.
Groups

IgA (g/L)

P

Sex

Regression
coefficients

IgM (g/L)

P

B

Female

33.75 ± 15.0

Male

25.82 ± 14.2

0.01*

8.80

Regression
coefficients
B

2.12 ± 1.4

0.01*

0.83

0.86

0.06

0.001*

−1.53

1.45 ± 0.9

Maternal age
18–30

29.16 ± 15.2

>30

29.75 ± 14.9

0.62

1.76

1.80 ±1.2
1.57 ±1.1

Parity
Primiparous

35.95 ± 15.7

Multiparous

27.33 ± 14.3

1.54 ± 1.0

General mean

29.37 ± 15.0

1.74 ± 1.2

0.01*

−10.5

2.73 ± 1.3

Data are presented as mean ± SD, and P-value from multiple linear regression analysis.
* P < 0.05.

the colostrum of mothers are reported in three primary
categories, i.e. maternal age, maternal parity, and infant
sex, on the first day of lactation (Table 2).
As anticipated, no significant differences were found in
TAS levels of colostrum across all three groups. The mean
TOS levels were significantly reduced in the colostrum
of mothers aged 18–30 years (2.57 ± 1.3) compared
with mothers aged >30 years (3.28 ± 1.4) (P = 0.038).
No significant differences were determined between
primiparous and multiparous mothers. Additionally, no
differences in the TOS levels in colostrum were observed
between male and female infants. The OSI provided an

integrative perspective for TAS and TOS levels in the
colostrum. In the current study, the OSI ratios in the
colostrum of mothers were observed to be higher after
age 30, when compared with the colostrum of mothers
aged 18–30 (P = 0.042). No significant differences were
found between primiparous and multiparous mothers.
No differences were determined for the colostrum OSI
between male and female infants.
IgA and IgM concentrations (Table 3) were significantly
higher in the colostrum of mothers of female infants
compared to mothers of male infants and higher in the
colostrum of primiparous compared with multiparous
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mothers. No significant differences existed between
maternal age and immunoglobulin concentrations.
4. Discussion
Breast milk and colostrum contain many antioxidant
constituents, including albumin, bilirubin, cysteine, uric
acid, glutathione, coenzyme Q10, lactoferrin, and vitamins
A, C, and E (12–14). In addition, breast milk contains
several times greater concentrations of antioxidant
enzymes catalase, superoxide dismutase, and glutathione
peroxidase than serum (15,16). Prior studies have noted
that breast-fed children may have higher albumin, uric
acid, vitamin C, and TAS levels than formula-fed children
do, even when formula milk contained much higher
concentrations of antioxidants and vitamins in vitro than
fresh breast milk did (12,17). Reports have shown that
TAS was higher in the colostrum than in transitional and
mature milk (18) and that the TAS levels of colostrum
was not affected by storage at −80 °C (19). Each of these
studies demonstrated the importance of colostrum and
mature milk consumption as an antioxidant source to
decrease the risk of disease due to the occurrence of an
imbalance between antioxidant status and oxidative
stress.
In this study, the importance of TAS in colostrum
samples on the first day of lactation was assessed. No
significant effects of maternal age, maternal parity,
or infant sex on colostrum TAS levels were observed.
This study demonstrated that TAS levels were constant
and did not change according to maternal or infant
characteristics. Consequently, colostrum is a constant
source of antioxidants that protect newborns postnatally
from higher oxygen levels than encountered prenatally.
Another finding was that TOS levels in the colostrum
were approximately 5 times less than in the blood serum
of healthy people (20,21). Both the high persistence of
TAS levels in the colostrum relative to blood serum (20)
and the up to 5 times less levels of TOS in the colostrum
may indicate that antioxidants and oxidants are selectively
passed to the colostrum, thereby providing increased
evidence of colostrum as important to life support.
Older mothers reported significantly higher TOS levels
than younger mothers (Table 3). In addition, this study
reported no significant difference between maternal
parity and infant sex with TOS levels of colostrum
compared to the TAS levels. Although the colostrum
TOS value exhibited concentrations approximately five
times less than in blood serum, an increased maternal age
caused increased transport of oxidants to the colostrum.
Therefore, it is possible to hypothesize that maternal age
is associated with colostrum quality.
The OSI is an important parameter that reveals the
general oxidant and antioxidant balance of colostrum
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on the first day of lactation because it is obtained from
proportioning the TAS and TOS levels. The OSI values
obtained in this study were significantly associated with
maternal age.
Colostrum contains more immunoglobulin than
mature milk and its concentration changes throughout
lactation (22). In contrast to our research, studies in
which milk samples were collected over longer lactation
periods, i.e. 1–3 or 1–5 days, report IgA concentrations in
the colostrum that differ from those reported in this study
and among each other, such as 10 g/L (23), 12 g/L (24),
5.61 g/L (6), 6.5 g/L (4), 2.25 g/L (5), and 17.4 g/L (25).
However, Hennart et al. reported dramatic differences
in the concentration of IgA between the first day and
second day of lactation. On the second day of lactation,
colostrum IgA concentrations were decreased by nearly
two-fold (26). Comparable studies reported that total
protein concentrations were also decreased in colostrum
by approximately two-fold between the first and third
days of lactation (27). A number of authors demonstrated
that the colostrum of primiparous mothers contained
higher IgA concentrations compared to multiparous
mothers (29,30), while others reported no difference in
the colostrum and mature milk (6,26). In the present
study, colostrum IgA concentrations were determined to
be significantly different between primiparous mothers
and multiparous mothers, 35.95 g/L and 27.33 g/L,
respectively. This unique spectrum of antibody specificity
is achieved by the “homing” of B lymphocytes, synthesized
in the mother’s gastrointestinal tract and transferred
to her mammary glands. The antibody composition
of breast milk compensates partly for the deficiency of
antibodies directed against enteric antigens in placentally
transferred IgG (31). In prolonged births in primiparous
mothers, fetuses can be exposed to enteric pathogens for
a long time, so they need more immunoglobulin. This
study demonstrated that no significant difference existed
between IgA concentrations and maternal age, and
was similar to that published previously for colostrum
(6,32). A sufficient amount of IgA is vital for a newborn
regardless of the age of the mother.
In conclusion, sex-based hormonal changes in
mothers during pregnancy may be associated with the
different colostral immunoglobulin levels for male and
female infants. The results of this study indicate that IgA
levels were significantly higher in colostrum consumed
by female infants. This study provides an exciting
opportunity to advance our knowledge of sex-based
changes in breast milk. Important in the first days of life,
the presence of higher amounts of immunoglobulins,
which are found in female infants compared to male
infants, could suggest better protection against various
diseases. In general, studies comparing infant sex and
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disease, such as middle ear infections (33), wheezing
(34), necrotizing enterocolitis (35), sudden infant death
syndrome (36), growth retardation (37), sepsis (38),
and deaths due to asphyxia (39), remarkably report
the occurrence of disease significantly more often in
male infants. Further research should be undertaken
to investigate the relationship between colostral
immunoglobulin levels and newborn’s disease.
Newborns have IgM production capacity to protect
against infection. For this reason, the rate of IgM tends
to fall gradually throughout breast-feeding (5). Similar
to IgA concentrations, the colostrum of primiparous

mothers contained higher IgM concentrations compared
to multiparous mothers (7). Although it is not yet clear
exactly how the number of births to an individual mother
influences the composition of the colostrum, previous
studies reported an effect on certain hormones, such as
prolactin (40). This study appears to be consistent with
other research that found no difference between maternal
age and the amount of IgM in the colostrum (6). The
present study determined that, similar to IgA, IgM levels
were significantly higher in the colostrum consumed by
female infants. Male sex was considered immunologically
disadvantageous compared to female infants.
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